These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 5844257)

  • 21. [Internal medicine treatment of pulmonary tuberculosis].
    Schaich W
    Med Klin; 1970 Sep; 65(36):1553-8. PubMed ID: 4995072
    [No Abstract]   [Full Text] [Related]  

  • 22. [The use of ethionamide in the treatment of primary infection in children].
    Guimard P; Gouyon C
    Rev Tuberc Pneumol (Paris); 1966 Dec; 30(12):1250-5. PubMed ID: 5299637
    [No Abstract]   [Full Text] [Related]  

  • 23. [Chemotherapeutic studies on advanced tuberculosis in mice].
    Grumbach F
    Bibl Tuberc; 1965; 21():31-96. PubMed ID: 4301034
    [No Abstract]   [Full Text] [Related]  

  • 24. [Preliminary clinical experiments with thioamid of alpha-propyl-isonocotinic acid (Trevintix) in pulmonary tuberculosis].
    Owsiński J; Piotrowska E
    Gruzlica; 1969 Apr; 37(4):309-14. PubMed ID: 4892237
    [No Abstract]   [Full Text] [Related]  

  • 25. [Tryptophan test in the assay of pyridoxine (vitamin B6) in patients with pulmonary tuberculosis with regard to treatment with INH and ETA].
    Sosnowski W; Rozniecki J; Galamon T; Lowkis L
    Gruzlica; 1968 Oct; 36(10):979-82. PubMed ID: 5710104
    [No Abstract]   [Full Text] [Related]  

  • 26. [Value of ethivanamide combined with isonicotinic acid hydrazine in the intermittent treatment of pulmonary tuberculosis].
    Krawczyk Z; Ratajek M; Sosnowski W
    Gruzlica; 1975 Oct; 43(10):921-7. PubMed ID: 1181252
    [No Abstract]   [Full Text] [Related]  

  • 27. Non-teratogenicity of antituberculous drugs.
    Marcus JC
    S Afr Med J; 1967 Aug; 41(30):758-9. PubMed ID: 6033370
    [No Abstract]   [Full Text] [Related]  

  • 28. [Treatment of chronic destructive forms of pulmonary tuberculosis with drugs of the second series in different combinations].
    Mamolat AS; Bialik IB
    Probl Tuberk; 1969; 47(6):23-8. PubMed ID: 4311969
    [No Abstract]   [Full Text] [Related]  

  • 29. [Possibilities and limitations of multiple chemoantibiotics in treatment of chronic pulmonary tuberculosis].
    Zanotelli F; Perusi O
    G Ital Mal Torace; 1966; 20(6):365-78. PubMed ID: 5997781
    [No Abstract]   [Full Text] [Related]  

  • 30. [On qualitative demonstration of tuberculostatics in the control of taking of drugs].
    Grunert M; Reutgen H; Iwainsky H
    Z Tuberk Erkr Thoraxorg; 1965; 124(3):141-8. PubMed ID: 5899136
    [No Abstract]   [Full Text] [Related]  

  • 31. [Effectiveness of the agents of the 2d series in treating patients with chronic destructive tuberculosis of the lungs].
    Utkin VV
    Probl Tuberk; 1973; 51(1):12-6. PubMed ID: 4727151
    [No Abstract]   [Full Text] [Related]  

  • 32. [Comparative study of specific blood activity in patients with fibrous-cavernous pulmonary tuberculosis during administration of different combinations of antibacterial preparations].
    Mkrtchian SV; Utkin VV; Egorkina ND
    Antibiotiki; 1970 Oct; 15(10):955-7. PubMed ID: 5487860
    [No Abstract]   [Full Text] [Related]  

  • 33. Position of cycloserine in the treatment of pulmonary tuberculosis.
    Meyer A; Nadjar G
    Scand J Respir Dis Suppl; 1970; 71():139-43. PubMed ID: 5271974
    [No Abstract]   [Full Text] [Related]  

  • 34. Cycloserine plus ethionamide plus pyrazinamide in the treatment of patients excreting isoniazid-resistant tubercle bacilli following previous chemotherapy.
    Ramakrishnan CV; Parthasarathy R; Sambamoorthy S; Somasundaram PR; Subbammal S
    Indian J Med Res; 1976 Jan; 64(1):76-82. PubMed ID: 818010
    [No Abstract]   [Full Text] [Related]  

  • 35. Cycloserine in the treatment of pulmonary tuberculosis.
    Aceves Ortega R; Cortés de la Peña F; Sanchez Ceceña S; Arreola Chavez C
    Scand J Respir Dis Suppl; 1970; 71():109-14. PubMed ID: 5271969
    [No Abstract]   [Full Text] [Related]  

  • 36. [Analytic study of 80 cases of pulmonary tuberculosis treated with the INH-STRE-PAS regime during 1971-2].
    Chabbou A; Maalej M; Zbiba M; El Gharbi T; El Mekki L; Chebbi ML; Djenayah F; Ben Salah M; El Gharbi B; Jeguirim M; Cherif M
    Tunis Med; 1974; 52(6):305-11. PubMed ID: 4619936
    [No Abstract]   [Full Text] [Related]  

  • 37. [Association of ethambutol-ethionamide or ethambutol-prothionamide in various forms of pulmonary tuberculosis].
    Meyer A; Nadjar-Fossé G
    Rev Tuberc Pneumol (Paris); 1969 Mar; 33(2):251-8. PubMed ID: 4247596
    [No Abstract]   [Full Text] [Related]  

  • 38. [Early and late results of the first "massive" antitubercular treatment using ETA].
    Sosnowski W; Rozniecki J; Kubiak Z
    Gruzlica; 1968 Oct; 36(10):1031-4. PubMed ID: 5710084
    [No Abstract]   [Full Text] [Related]  

  • 39. [Pulmonary tuberculosis resistant to streptomycin and isoniazid and treated wtih a combination of ethionamide, pyrazinamide, and cycloserine (200 cases)].
    Bartal M; Nejjar A; Laraki A
    Tunis Med; 1973 Jul; 51(4):237-43. PubMed ID: 4209977
    [No Abstract]   [Full Text] [Related]  

  • 40. [Therapy of pulmonary tuberculosis in its current aspects].
    Gartmann JC
    Bibl Tuberc; 1965; 20():59-70. PubMed ID: 4291161
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.